» Articles » PMID: 31181590

High Fructose Intake and Adipogenesis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jun 12
PMID 31181590
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

In modern societies, high fructose intake from sugar-sweetened beverages has contributed to obesity development. In the diet, sucrose and high fructose corn syrup are the main sources of fructose and can be metabolized in the intestine and transported into the systemic circulation. The liver can metabolize around 70% of fructose intake, while the remaining is metabolized by other tissues. Several tissues including adipose tissue express the main fructose transporter GLUT5. In vivo, chronic fructose intake promotes white adipose tissue accumulation through activating adipogenesis. In vitro experiments have also demonstrated that fructose alone induces adipogenesis by several mechanisms, including (1) triglycerides and very-low-density lipoprotein (VLDL) production by fructose metabolism, (2) the stimulation of glucocorticoid activation by increasing 11β-HSD1 activity, and (3) the promotion of reactive oxygen species (ROS) production through uric acid, NOX and XOR expression, mTORC1 signaling and Ang II induction. Moreover, it has been observed that fructose induces adipogenesis through increased ACE2 expression, which promotes high Ang-(1-7) levels, and through the inhibition of the thermogenic program by regulating Sirt1 and UCP1. Finally, microRNAs may also be involved in regulating adipogenesis in high fructose intake conditions. In this paper, we propose further directions for research in fructose participation in adipogenesis.

Citing Articles

Voluntary physical activity suppresses adipocyte hypertrophy through the activation of cGMP mediated pathway in a fructose-induced metabolic syndrome model in rat.

Tayfur P, Palabiyik O, Meric B, Tastekin E, Vardar S Eur J Nutr. 2025; 64(2):91.

PMID: 39954126 PMC: 11829920. DOI: 10.1007/s00394-025-03613-0.


The role of the estimated glomerular filtration rate and body roundness index in the risk assessment of uric acid-lowering therapy-resistant gout in U.S. adults: evidence from the National Health and Nutrition Examination Survey (2007-2018).

Zhu M, Wang X, Peng Z, Yan W, Deng Q, Li M Ren Fail. 2025; 47(1):2441398.

PMID: 39910828 PMC: 11803761. DOI: 10.1080/0886022X.2024.2441398.


The Effect of Diaphragmatic Breathing as a Complementary Therapeutic Strategy in Stress of Children and Teenagers 6-18 Years Old.

Tsakona P, Kitsatis I, Apostolou T, Papadopoulou O, Hristara-Papadopoulou A Children (Basel). 2025; 12(1).

PMID: 39857890 PMC: 11763547. DOI: 10.3390/children12010059.


Associations of renal sinus fat with metabolic parameters, abdominal visceral adipose tissue, metabolic syndrome, fructose intake, and blood pressure control in obese individuals with hypertension: a cross-sectional study.

Anvarifard P, Anbari M, Naemi Kermanshahi M, Ostadrahimi A, Aliasgharzadeh S, Ardalan M J Nutr Sci. 2024; 13:e94.

PMID: 39703900 PMC: 11658955. DOI: 10.1017/jns.2024.84.


Fructose restriction has beneficial effects on adipose tissue distribution but not on serum adipokine levels: Post-hoc analysis of a double-blind randomized controlled trial.

van Oeteren M, Simons N, Simons P, van de Waarenburg M, Kooi M, Feskens E Clin Obes. 2024; 15(1):e12714.

PMID: 39468417 PMC: 11706758. DOI: 10.1111/cob.12714.


References
1.
Le M, Frye R, Rivard C, Cheng J, McFann K, Segal M . Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects. Metabolism. 2011; 61(5):641-51. PMC: 3306467. DOI: 10.1016/j.metabol.2011.09.013. View

2.
London E, Castonguay T . High fructose diets increase 11β-hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure. Obesity (Silver Spring). 2010; 19(5):925-32. DOI: 10.1038/oby.2010.284. View

3.
Jang C, Hui S, Lu W, Cowan A, Morscher R, Lee G . The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids. Cell Metab. 2018; 27(2):351-361.e3. PMC: 6032988. DOI: 10.1016/j.cmet.2017.12.016. View

4.
Tang R, Ma F, Li W, Ouyang S, Liu Z, Wu J . miR-206-3p Inhibits 3T3-L1 Cell Adipogenesis via the c-Met/PI3K/Akt Pathway. Int J Mol Sci. 2017; 18(7). PMC: 5536000. DOI: 10.3390/ijms18071510. View

5.
Shi C, Zhang M, Tong M, Yang L, Pang L, Chen L . miR-148a is Associated with Obesity and Modulates Adipocyte Differentiation of Mesenchymal Stem Cells through Wnt Signaling. Sci Rep. 2015; 5:9930. PMC: 4441322. DOI: 10.1038/srep09930. View